0001209191-12-002591.txt : 20120106
0001209191-12-002591.hdr.sgml : 20120106
20120106172229
ACCESSION NUMBER: 0001209191-12-002591
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120104
FILED AS OF DATE: 20120106
DATE AS OF CHANGE: 20120106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finestone Arnold
CENTRAL INDEX KEY: 0001422489
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09927
FILM NUMBER: 12515508
MAIL ADDRESS:
STREET 1: 1211 N. WESTSHORE BLVD.
STREET 2: SUITE 512
CITY: TAMPA
STATE: FL
ZIP: 33607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMPREHENSIVE CARE CORP
CENTRAL INDEX KEY: 0000022872
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 952594724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
BUSINESS PHONE: 813-288-4808
MAIL ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES
DATE OF NAME CHANGE: 19730501
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC
DATE OF NAME CHANGE: 19700402
FORMER COMPANY:
FORMER CONFORMED NAME: JADE OIL CO
DATE OF NAME CHANGE: 19700402
4
1
doc4.xml
FORM 4 SUBMISSION
X0304
4
2012-01-04
0
0000022872
COMPREHENSIVE CARE CORP
CHCR
0001422489
Finestone Arnold
3405 W DR MARTIN LUTHER KING JR, BLVD
SUITE 101
TAMPA
FL
33607
1
0
0
0
Warrant to purchase Series D Convertible Preferred Stock
25000.00
2012-01-04
4
D
0
6
25000.00
D
2009-03-31
2012-03-31
Series D Convertible Preferred Stock
6
0
D
Series D Convertible Preferred Stock
2012-01-04
4
A
0
50
0.00
A
2022-01-04
Common Stock
5000000
50
D
On December 29, 2011 the Board of Directors approved a restricted stock grant of the Series D Convertible Preferred Stock ("Series D Stock"), which was granted to the Reporting Person on January 4, 2012. As a condition of the grant, the Reporting Person surrendered for cancellation all warrants for the purchase of shares of Series D Stock held by the Reporting Person. The restricted shares of Series D Stock will vest on the 10th anniversary of the grant date. The restricted shares will, however, have the voting, dividend, liquidation and other rights of a share of Series D Stock effective from the date of grant. After the 10th anniversary of the grant date, each share of Series D Stock may be converted into 100,000 shares of the Issuer's Common Stock. Shares of Series D Stock have no expiration date.
/s/ Scott Bates as attorney-in-fact for Arnold B. Finestone
2012-01-06